You are here

Anti-Inflammatory Compounds

12.09.2010

Also in:

 Prof. David Wallach
 
For nearly two decades, Prof. David Wallach has studied receptors for the tumor necrosis factor, or TNF, an immune system substance that controls the damaging processes associated with inflammation. In these studies, Wallach identified two classes of proteins that block TNF activity.
 

Application

 
The proteins identified by Wallach are being used in clinical trials as anti-inflammatory compounds that may control rheumatoid arthritis and inflammatory bowel diseases (Crohn's disease and colitis).
 

Please share if you found this interesting:

 

 

 

 

Instagram